CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
High ImpactOriginal article

Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026

NDA FilingREVTORPYKPositive
AI Analysis

Summary

Celcuity expects FDA approval of REVTORPYK with a supplemental NDA for label expansion anticipated in Q3 2026.

Outcome Details

FDA approval expected; sNDA label expansion planned

Importance:8/10
Sentiment:
0.70
FDA approvallabel expansionsNDA
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 15, 2026 5:45 PM

Read Original